OneAscent Family Office LLC Grows Position in STERIS plc $STE

OneAscent Family Office LLC boosted its stake in shares of STERIS plc (NYSE:STE) by 13.9% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 2,040 shares of the medical equipment provider’s stock after purchasing an additional 249 shares during the period. OneAscent Family Office LLC’s holdings in STERIS were worth $490,000 at the end of the most recent reporting period.

A number of other hedge funds also recently made changes to their positions in STE. Ashton Thomas Private Wealth LLC increased its holdings in shares of STERIS by 3.5% during the 1st quarter. Ashton Thomas Private Wealth LLC now owns 1,611 shares of the medical equipment provider’s stock worth $365,000 after buying an additional 54 shares during the last quarter. Cetera Investment Advisers increased its stake in STERIS by 0.9% during the first quarter. Cetera Investment Advisers now owns 6,999 shares of the medical equipment provider’s stock worth $1,586,000 after acquiring an additional 63 shares during the last quarter. Horizon Investments LLC raised its holdings in shares of STERIS by 4.7% in the 1st quarter. Horizon Investments LLC now owns 1,410 shares of the medical equipment provider’s stock worth $320,000 after purchasing an additional 63 shares during the period. Alliance Wealth Advisors LLC UT raised its holdings in shares of STERIS by 2.0% in the 1st quarter. Alliance Wealth Advisors LLC UT now owns 3,305 shares of the medical equipment provider’s stock worth $749,000 after purchasing an additional 64 shares during the period. Finally, Sagespring Wealth Partners LLC lifted its stake in shares of STERIS by 1.2% in the 2nd quarter. Sagespring Wealth Partners LLC now owns 5,319 shares of the medical equipment provider’s stock valued at $1,278,000 after purchasing an additional 64 shares in the last quarter. Institutional investors and hedge funds own 94.69% of the company’s stock.

STERIS Stock Up 0.6%

Shares of STERIS stock opened at $243.24 on Thursday. STERIS plc has a 1-year low of $200.98 and a 1-year high of $253.00. The company has a market capitalization of $23.96 billion, a PE ratio of 37.25 and a beta of 1.02. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.22 and a quick ratio of 1.53. The business has a 50-day moving average of $243.30 and a 200-day moving average of $238.43.

STERIS (NYSE:STE) last released its quarterly earnings results on Wednesday, November 5th. The medical equipment provider reported $2.47 EPS for the quarter, topping the consensus estimate of $2.38 by $0.09. STERIS had a return on equity of 14.17% and a net margin of 11.61%.The business had revenue of $1.50 billion for the quarter, compared to analysts’ expectations of $1.43 billion. During the same quarter in the previous year, the firm posted $2.14 earnings per share. STERIS has set its FY 2026 guidance at 10.150-10.30 EPS. As a group, equities analysts forecast that STERIS plc will post 9.08 EPS for the current fiscal year.

STERIS Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, December 18th. Investors of record on Tuesday, November 18th will be paid a $0.63 dividend. This represents a $2.52 dividend on an annualized basis and a dividend yield of 1.0%. The ex-dividend date is Tuesday, November 18th. STERIS’s payout ratio is 38.59%.

Wall Street Analyst Weigh In

A number of research firms recently issued reports on STE. Weiss Ratings reissued a “buy (b)” rating on shares of STERIS in a research report on Tuesday, October 14th. Morgan Stanley raised their target price on shares of STERIS from $276.00 to $295.00 and gave the company an “overweight” rating in a research note on Friday, August 8th. Wall Street Zen upgraded shares of STERIS from a “buy” rating to a “strong-buy” rating in a report on Sunday, September 14th. Finally, KeyCorp increased their price target on STERIS from $277.00 to $288.00 and gave the company an “overweight” rating in a report on Tuesday, July 22nd. Seven research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $273.50.

Insider Transactions at STERIS

In other news, Director Mohsen Sohi sold 4,110 shares of the business’s stock in a transaction dated Monday, August 11th. The shares were sold at an average price of $241.96, for a total value of $994,455.60. Following the completion of the sale, the director owned 22,361 shares of the company’s stock, valued at approximately $5,410,467.56. The trade was a 15.53% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CAO Karen L. Burton sold 7,900 shares of the company’s stock in a transaction dated Monday, August 11th. The shares were sold at an average price of $241.73, for a total transaction of $1,909,667.00. Following the completion of the sale, the chief accounting officer owned 5,994 shares in the company, valued at approximately $1,448,929.62. This trade represents a 56.86% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 18,868 shares of company stock valued at $4,585,389 over the last ninety days. 1.07% of the stock is currently owned by corporate insiders.

About STERIS

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.